| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |